Skip to content
Catalyst

PapersPMID:28447512

Centella asiatica enhances hepatic antioxidant status and regulates hepatic inflammatory cytokines in type 2 diabetic rats.

Pharmaceutical biology2017The record ↗

  1. Finding, very limited evidencelowersTriglycerides

What moved

1 findingHow to read these marks →
  • “Treatment of the diabetic animals with CA significantly (p < 0.05) decreased serum TG concentration when compared to diabetic controls.”
    Study
    animal · not in humans
    Duration
    14 days
    Dose studied
    500 mg/kg b.wt daily by oral dosing for 14 days
    Population
    Male Sprague-Dawley rats with type 2 diabetes induced by 10% fructose for 14 days then streptozotocin 40 mg/kg i.p.; diabetic CA group versus diabetic control

Study record

Design
animal study, in vivo
Species
animal
Population
Male Sprague-Dawley rats (150–180 g) with type 2 diabetes induced by 10% fructose in drinking water then low-dose streptozotocin; dosed material is a methanol extract of Centella asiatica leaves (CA)
Participants
not reported
Comparator
an active treatment / placebo
Duration
not reported
Endpoints measured
82